期刊文献+

外科创新技术/器械临床研究方法学——IDEAL框架与推荐系列文章之一:IDEAL框架与推荐介绍 被引量:5

The methodological framework of surgical innovation:the introduction of IDEAL framework and recommendation
原文传递
导出
摘要 外科技术和器械的快速创新是外科临床研究和实践的重要内容,其评价总体思路与药物干预类似,但具体方法学存在很大差异。2009年IDEAL协作网提出一套适用于外科创新干预的方法学框架—IDEAL框架,将外科创新技术发展分为5个阶段,涵盖从概念提出到推广应用的全生命周期。2019年,协作网更新IDEAL框架,在原有基础上增加临床前评价(Pre-IDEAL),梳理明确各阶段研究目的、核心问题和伦理依据。作为IDEAL框架和推荐系统的首篇文章,本文将详细介绍IDEAL推荐和框架的产生、发展、具体内容、应用推广现状,旨在促进该方法在国内外科临床研究领域的应用和传播。 Surgical innovation is an important part of surgical research and practice.The evaluation of surgical innovation through the stages is similar to those for drug development,but with important differences.The Idea,Development,Exploration,Assessment,and Long-term follow-up(IDEAL)Framework and Recommendations represent a new paradigm for the evaluation of surgical intervention and devices which was developed in 2009.The IDEAL is a fivestage framework involving the nature stages of surgical innovation,together with recommendations for surgical research pathway.The Framework and Recommendations were updated and published in 2019,which added a pre-IDEAL stage if necessary.The updated IDEAL also underlines the purpose,key question and ethical issues for each stage.In the first paper of IDEAL Framework and Recommendations series,we conducted a comprehensive introduction of IDEAL(e.g.the development,updates and application of IDEAL)to promote the dissemination and application of IDEAL in China.
作者 喻佳洁 陕飞 Peter McCulloch Allison Hirst 胡建昆 孙鑫 李幼平 刘伦旭 刘雪梅 董念国 陈寄梅 乔贵宾 李鹤成 YU Jiajie;SHAN Fei;Peter McCulloch;Allison Hirst;HU Jiankun;SUN Xin;LI Youping;LIU Lunxu;LIU Xuemei;DONG Lianguo;CHEN Jimei;QIAO Guibin;LI Hecheng(Chinese Evidence-based Medicine Center,West China Hospital,Sichuan University,Chengdu,610041,P.R.China;Gastrointestinal Cancer Center,Peking University Cancer Hospital&Institute,Beijing,100142,P.R.China;IDEAL Collaboration,Nuffield Department of Surgical Sciences,University of Oxford,Oxford,OX39DU,United Kingdom;Department of Gastrointestinal Surgery&Laboratory of Gastric Cancer,West China Hospital,Sichuan University,Chengdu,610041,P.R.China;Real World Data Research and Innovation Center of Boao Lecheng,Qionghai,571435,Hainan,P.R.China;Department of Thoracic Surgery,West China Hospital,Sichuan University,Chengdu,610041,P.R.China;Chinese Clinical Journal of Thoracic and Cardiovascular Surgery,West China Hospital,Sichuan University,Chengdu,610041,P.R.China;Department of Cardiovascular Surgery,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,430022,P.R.China;Guangdong Provincial Cardiovascular Institute,Guangdong Provincial People’s Hospital,Guangdong Provincial Key Laboratory of South China Structural Heart Disease,Guangzhou,510080,P.R.China;Department of Thoracic Surgery,Guangdong Provincial People’s Hospital,Guangzhou,510080,P.R.China;Department of Thoracic Surgery,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,200025,P.R.China)
出处 《中国胸心血管外科临床杂志》 CSCD 北大核心 2021年第2期131-136,共6页 Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
基金 国家自然科学基金(71704120)。
关键词 外科创新 框架与推荐 IDEAL 临床研究 Surgical innovation framework and recommendation IDEAL clinical trial
  • 相关文献

参考文献1

共引文献11

同被引文献7

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部